
Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. (BPTH) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · BPTH · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Bio-Path Holdings, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
BPTH insider buying and selling by quarter
BPTH insider selling · BPTH insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
BPTH executive sell shares · BPTH board member insider trading · BPTH insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jan 18, 2019 | ARMISTICE CAPITAL, LLC 10 percent owner | Sale | 64,457 | $172K | Form 4 |
| Jul 13, 2015 | Garrison Michael J. Director | Purchase | 7,343 | $9K | Form 4 |
| Jul 9, 2015 | Garrison Michael J. Director | Purchase | 8,724 | $10K | Form 4 |
| Jul 8, 2015 | Garrison Michael J. Director | Purchase | 21,015 | $25K | Form 4 |
| Jul 7, 2015 | Garrison Michael J. Director | Purchase | 38,985 | $46K | Form 4 |
| Jul 1, 2015 | Garrison Michael J. Director | Other | 600 | $648 | Form 4 |
| Jun 12, 2013 | Garrison Michael J. Director | Purchase | 340,000 | $102K | Form 4 |
ARMISTICE CAPITAL, LLC
10 percent owner
Date
Jan 18
Shares
64,457
Price
$2.66
Value
$172K
Garrison Michael J.
Director
Date
Jun 12
Shares
340,000
Price
$0.30
Value
$102K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About BPTH insider trading
BPTH insider trades
Bio-Path Holdings, Inc. (BPTH) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including BPTH. Over the past 12 months, 0 insiders have filed transactions with the SEC. BPTH insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Bio-Path Holdings, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
BPTH insider trading · 5 questionsThe insiders of Bio-Path Holdings, Inc. (BPTH) include executives and directors such as BPTH, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026